Adding Nubeqa to androgen deprivation therapy improved radiographic progression-free survival in patients with metastatic hormone-sensitive prostate cancer. The combination of Nubeqa (darolutamide) ...
Darolutamide plus androgen deprivation therapy (ADT), without docetaxel, significantly prolonged radiographic progression-free survival compared with placebo plus ADT in patients with metastatic ...
ADT announced its new ADT Plus smart security system, which features new hardware and more integration possibilities with Google Nest cameras and video doorbells. It also allows you to set up trusted ...
Posts from this topic will be added to your daily email digest and your homepage feed. A Trusted Neighbor feature, coming to the new ADT Plus system, automates access to your home for people you trust ...
Chinese NMPA approves Bayer’s oral ARi Nubeqa in combo with ADT for use in patients with metastatic hormone-sensitive prostate cancer: Berlin Wednesday, February 4, 2026, 14:00 ...
PCa Diagnoses Fall in Wake of USPSTF Screening Recommendation Adding bevacizumab to androgen deprivation therapy (ADT) resulted in improved relapse-free survival in patients with hormone-sensitive ...
Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non–Small-Cell Lung Cancer ...
BOCA RATON, Fla. — In spite of challenging market conditions ADT has shown admirable financial growth in the third quarter thanks to bulk account acquisition and partnerships with other major ...
BOCA RATON, Fla. — ADT entered the second half of 2025 with 4% total revenue growth, amid a slight dip in recurring monthly revenue (RMR), but the company remains confident in the strength of its ...
Hosted on MSN
An Honest Review of ADT Home Security
Latest News: ADT’s current offers include a free Google Nest Doorbell and a Yale Smart Lock when you order a minimum of $640 worth of equipment and sign up for a Pro Monitoring plan. In addition, the ...
A 1-year period of intensified androgen receptor blockade prolonged prostate-specific antigen progression-free survival (PSA-PFS) compared with androgen deprivation therapy (ADT) alone for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results